Categories Earnings, Retail

Campbell Soup reports market-beating third quarter earnings

Campbell Soup Company (CPB) reported a 15% increase in sales to $2.12 billion for the third quarter of 2018, helped by the acquisitions of Snyder’s-Lance and Pacific Foods. The company reported a net loss of $393 million or $1.31 per share for the quarter, compared to a net income of $176 million or $0.58 per share in the same period last year. Adjusted EPS increased 19% to $0.70, beating market estimates.

In the Americas Simple Meals and Beverages segment, sales increased 5% to $1 billion, aided by benefits from the Pacific Foods acquisition. In Global Biscuit and Snacks, sales grew 35% to $862 million. In Campbell Fresh, sales improved 1% to $251 million.

Campbell Soup revised its guidance for fiscal year 2018 due to expenses associated with the Snyder’s-Lance acquisition. Net sales for the year are expected to grow 10% to 11%. Adjusted EPS is now expected to be $2.85 to $2.90, down 5% to 6%.

Campbell’s CEO Denise Morrison announced that she will depart from the company without providing any reason for her decision. Morrison will be replaced by board member Keith McLoughlin who will act as interim CEO.

Shares dropped around 3% premarket following the news of the CEO’s exit and the slashed EPS guidance.

Campbell Soup third quarter 2018 earnings
Campbell Soup Q3 2018 Earnings Infographic

Under Morrison, the company tried to revive its soups business and attempted to expand into the snacks space through the purchase of Snyder’s-Lance. Campbell has been facing extensive competition as well as pressure on sales as consumer preferences shift more towards healthier options. Following the departure of its CEO, the company is planning to undertake a strategic review.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top